肥胖与抑郁症状的关联中生物标志物的作用——横断面研究
The Role of Biomarkers in the Association between Obesity and Depressive Symptoms—A Cross-Sectional Study
DOI: 10.12677/ap.2026.1611548, PDF,    科研立项经费支持
作者: 戴雪凝, 袁晨曦*, 郑思远, 陈 晨, 沈孜琪, 李迎君:杭州医学院公共卫生学院,浙江 杭州
关键词: 肥胖;抑郁症状;C反应蛋白;效应修饰;横断面研究;Obesity; Depressive Symptoms; C-Reactive Protein; Effect Modification; Cross-Sectional Study
摘要: 背景:多项流行病学研究揭示肥胖与抑郁存在显著关联,但其生物学机制尚未明确。生物标志物在解释该关联中的作用,以及性别与年龄的效应修饰,仍缺乏系统评估。目的:探讨肥胖与抑郁的关联,量化多种生物标志物(包括C反应蛋白)对该关联的解释程度,并评估性别与年龄的效应修饰作用。方法:采用横断面研究设计,基于英国生物银行(UK Biobank, UKB)数据,纳入132,662名40~69岁参与者。肥胖定义为身体质量指数(Body Mass Index, BMI) ≥ 30 kg/m2,抑郁定义为患者健康问卷-9 (Patient Health Questionnaire-9, PHQ-9)评分 ≥ 10分。采用多变量logistic回归模型评估肥胖与抑郁的关联,逐步调整人口学特征、生活方式及生物标志物。基于Bootstrap重抽样(1000次)估计生物标志物的关联强度的统计学衰减比例及其95%置信区间;采用似然比检验评估交互作用,并开展性别与年龄分层分析。采用错误发现率法(False Discovery Rate, FDR)校正多重比较,并通过多项敏感性分析检验结果稳健性。结果:肥胖与抑郁显著相关。调整人口学特征、生活方式及生物标志物后,肥胖者发生抑郁的风险增加58% (OR = 1.58, 95% CI: 1.46~1.70)。性别与肥胖存在显著交互作用(P = 0.019),女性中该关联强于男性(OR = 1.99 vs 1.71)。分层分析显示,女性40~50岁组关联最强(OR = 2.16),男性61~69岁组最弱(OR = 1.68)。在所评估的生物标志物中,C反应蛋白与肥胖–抑郁关联强度的统计学衰减关系最为明显,其衰减比例为23.17%;在61~69岁女性中达31.75% (95% CI: 16.88%~52.88%);空腹血糖及多数血脂指标对应的衰减比例较低且无统计学显著性。敏感性分析结果一致。结论:肥胖与抑郁症状显著相关;炎症水平与该关联的强度显著相关,且该关联受性别与年龄修饰。中年女性肥胖人群或为抑郁防控的重点干预对象。鉴于横断面设计,上述衰减比例仅反映关联强度的统计学变化,不能解释为已证实的因果中介路径,需纵向研究进一步验证。
Abstract: Background: Numerous epidemiological studies have revealed a significant association between obesity and depression; however, the underlying biological mechanisms remain unclear. The role of biomarkers in explaining this association, as well as the effect modification by sex and age, has not been systematically evaluated. Objective: To investigate the association between obesity and depression, quantify the explanatory contribution of multiple biomarkers (including C-reactive protein) to this association, and assess the effect modification by sex and age. Methods: This cross-sectional study used data from the UK Biobank (UKB), including 132,662 participants aged 40~69 years. Obesity was defined as body mass index (BMI) ≥ 30 kg/m2, and depression as a Patient Health Questionnaire-9 (PHQ-9) score ≥ 10. Multivariable logistic regression models were used to assess the association between obesity and depression, with stepwise adjustment for demographic characteristics, lifestyle factors, and biomarkers. Bootstrap resampling (1000 replicates) was used to estimate the proportion of the association explained by each biomarker and its 95% confidence interval (CI). Likelihood ratio tests were used to assess interactions, and stratified analyses by sex and age were conducted. The false discovery rate (FDR) method was used to correct for multiple comparisons, and multiple sensitivity analyses were performed to verify robustness. Results: Obesity was significantly associated with depression. After adjusting for demographic characteristics, lifestyle factors, and biomarkers, obese individuals had a 58% increased risk of depression (OR = 1.58, 95% CI: 1.46~1.70). A significant interaction between sex and obesity was observed (P = 0.019), with a stronger association in women than in men (OR = 1.99 vs. 1.71). Stratified analyses showed that the association was strongest in women aged 40~50 years (OR = 2.16) and weakest in men aged 61~69 years (OR = 1.68). Among the biomarkers assessed, C-reactive protein exhibited the most pronounced statistical attenuation in the strength of the association between obesity and depression, with an attenuation rate of 23.17%; this reached 31.75% (95% CI: 16.88%~52.88%) in women aged 61~69 years; the corresponding attenuation rates for fasting blood glucose and most lipid parameters were lower and not statistically significant. The results of the sensitivity analyses were consistent. Conclusion: Obesity is significantly associated with depressive symptoms; levels of inflammation are significantly associated with the strength of this association, which is modified by sex and age. Obese middle-aged women may represent a key target group for depression prevention and control. Given the cross-sectional design, the attenuation rates described above merely reflect statistical variations in the strength of the association and cannot be interpreted as confirmed causal mediation pathways; further validation through longitudinal studies is required.
文章引用:戴雪凝, 袁晨曦, 郑思远, 陈晨, 沈孜琪, 李迎君 (2026). 肥胖与抑郁症状的关联中生物标志物的作用——横断面研究. 心理学进展, 16(11), 265-279. https://doi.org/10.12677/ap.2026.1611548

参考文献

[1] 杨会增, 杨程皓(2022). 抑郁症抗炎治疗的研究进展. 临床精神医学杂志, 32(6), 492-496.
[2] Berney, A., Pistis, G., Strippoli, M. F., Castelao, E., Ranjbar, S., Vollenweider, P. et al. (2025). Familial and Genetic Relationships of Major Depressive Disorders and Adiposity Markers in the Community. Translational Psychiatry, 15, Article No. 445.
https://doi.org/10.1038/s41398-025-03659-y
[3] Beydoun, M. A., Georgescu, M. F., Weiss, J., Noren Hooten, N., Beydoun, H. A., Tsai, J. et al. (2025). Socioeconomic Area Deprivation and Its Relationship with Dementia, Parkinson’s Disease and All-Cause Mortality among UK Older Adults: A Multistate Modeling Approach. Social Science & Medicine, 379, Article 118137.
https://doi.org/10.1016/j.socscimed.2025.118137
[4] Castanon, N., Vancassel, S., Amadieu, C., Cussotto, S., Leyrolle, Q., Lucas, C. et al. (2025). Obesity-Induced Emotional Alterations in Mice Are Associated with Impairments of Tryptophan Metabolism along the Kynurenine and Indole Pathways. Brain, Behavior, and Immunity, 130, Article 106659.
https://doi.org/10.1016/j.bbi.2026.106659
[5] Chae, W. R., Nübel, J., Baumert, J., Gold, S. M., & Otte, C. (2022). Association of Depression and Obesity with C-Reactive Protein in Germany: A Large Nationally Representative Study. Brain, Behavior, and Immunity, 103, 223-231.
https://doi.org/10.1016/j.bbi.2022.04.024
[6] Chen, X. D., Li, F., Zuo, H. et al. (2025). Trends in Prevalent Cases and Disability‐Adjusted Life‐Years of Depressive Disorders Worldwide: Findings from the Global Burden of Disease Study from 1990 to 2021. Depression and Anxiety, 2025, Article 6669207.
https://doi.org/10.1155/da/5553491
[7] Chinman, M., Wang, T., Dodge, J. R., Frank, D. A., McCoy, J. L., & Cohen, A. N. (2026). Tailored Weight Loss Programs for Adults with Serious Mental Illness: A Randomized Clinical Trial. JAMA Psychiatry, 83, 139-148.
https://doi.org/10.1001/jamapsychiatry.2025.3828
[8] Cho, S. H., Lim, J., Lee, J., Lee, J. S., Jeong, H., Lee, M. et al. (2021). Association between High-Sensitivity C-Reactive Protein Levels and Depression: Moderation by Age, Sex, Obesity, and Aerobic Physical Activity. Journal of Affective Disorders, 291, 375-383.
https://doi.org/10.1016/j.jad.2021.05.040
[9] Chung, W. T., & Chung, K. C. (2023). The Use of the E-Value for Sensitivity Analysis. Journal of Clinical Epidemiology, 163, 92-94.
https://doi.org/10.1016/j.jclinepi.2023.09.014
[10] Dakanalis, A., Mentzelou, M., Papadopoulou, S. K., Papandreou, D., Spanoudaki, M., Vasios, G. K. et al. (2023). The Association of Emotional Eating with Overweight/Obesity, Depression, Anxiety/Stress, and Dietary Patterns: A Review of the Current Clinical Evidence. Nutrients, 15, Article 1173.
https://doi.org/10.3390/nu15051173
[11] Dębski, J., Przybyłowski, J., Skibiak, K., Czerwińska, M., Walędziak, M., & Różańska-Walędziak, A. (2024). Depression and Obesity—Do We Know Everything about It? A Narrative Review. Nutrients, 16, Article 3383.
https://doi.org/10.3390/nu16193383
[12] Deng, J., He, L., Zhang, L., Wang, J., Fu, Q., Ding, R. et al. (2025). The Association between Metabolically Healthy Obesity and Risk of Depression: A Systematic Review and Meta-Analysis. International Journal of Obesity, 49, 980-991.
https://doi.org/10.1038/s41366-025-01741-5
[13] Dong, X., Aveyard, P., Yang, X., Kivimaki, M., Chen, S., Firth, J. et al. (2025). Adiposity and the First-Onset of Diagnosed Mental Illnesses: A Population-Based Cohort Study of 10 Million UK Adults. BMC Medicine, 24, Article No. 5.
https://doi.org/10.1186/s12916-025-04514-z
[14] Fanelli, G., Bralten, J., Franke, B., Roth Mota, N., Atti, A. R., De Ronchi, D. et al. (2026). Insulin Resistance and Poorer Treatment Outcomes in Depression: Evidence from UK Biobank Primary Care Data. The British Journal of Psychiatry, 229, 26-35.
https://doi.org/10.1192/bjp.2025.82
[15] Frank, P., Jokela, M., Batty, G. D., Lassale, C., Steptoe, A., & Kivimäki, M. (2022). Overweight, Obesity, and Individual Symptoms of Depression: A Multicohort Study with Replication in UK Biobank. Brain, Behavior, and Immunity, 105, 192-200.
https://doi.org/10.1016/j.bbi.2022.07.009
[16] Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S. (2022). The Menace of Obesity to Depression and Anxiety Prevalence. Trends in Endocrinology & Metabolism, 33, 18-35.
https://doi.org/10.1016/j.tem.2021.10.005
[17] Guo, Y. X., Wang, A. Q., Gao, X. et al. (2023). Obesity Is Positively Associated with Depression in Older Adults: Role of Systemic Inflammation. Biomedical and Environmental Sciences, 36, 481-489.
[18] Institute for Health Metrics and Evaluation (2025). Global Burden of Disease Study 2021 (GBD 2021) Results [Data Set].
https://vizhub.healthdata.org/gbd-results/
[19] Jokela, M., & Laakasuo, M. (2023). Obesity as a Causal Risk Factor for Depression: Systematic Review and Meta-Analysis of Mendelian Randomization Studies and Implications for Population Mental Health. Journal of Psychiatric Research, 163, 86-92.
https://doi.org/10.1016/j.jpsychires.2023.05.034
[20] Jung, F. U., Bleck, F., Pabst, A., Schladitz, K., Luppa, M., Hussenoeder, F. S. et al. (2025). Depressive Symptoms in Individuals with Overweight and Obesity. Results from the Life-Adult-Study. Journal of Affective Disorders, 390, Article 119792.
https://doi.org/10.1016/j.jad.2025.119792
[21] Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine, 16, 606-613.
https://doi.org/10.1046/j.1525-1497.2001.016009606.x
[22] Köse, A. M., Petzold, P., Zocholl, D., Kostoulas, P., Rose, M., & Fischer, F. (2025). Prevalence Estimation Using a Depression Screening Tool in the National Health and Nutrition Examination Survey: Comparison of Different Cutoffs. International Journal of Methods in Psychiatric Research, 34, e70019.
https://doi.org/10.1002/mpr.70019
[23] Meng, X., Han, L., Fu, J., Hu, C., & Lu, Y. (2025). Associations between Metabolic Syndrome and Depression, and the Mediating Role of Inflammation: Based on the NHANES Database. Journal of Affective Disorders, 375, 214-221.
https://doi.org/10.1016/j.jad.2025.01.108
[24] Musial, N., Ali, Z., Grbevski, J., Veerakumar, A., & Sharma, P. (2021). Perimenopause and First-Onset Mood Disorders: A Closer Look. Focus, 19, 330-337.
https://doi.org/10.1176/appi.focus.20200041
[25] Opel, N., Hanssen, R., Steinmann, L. A., Foerster, J., Köhler-Forsberg, O., Hahn, M. et al. (2025). Clinical Management of Major Depressive Disorder with Comorbid Obesity. The Lancet Psychiatry, 12, 780-794.
https://doi.org/10.1016/s2215-0366(25)00193-2
[26] Otte, C., Chae, W. R., Dogan, D. Y., Piber, D., Roepke, S., Cho, A. B. et al. (2025). Simvastatin as Add-On Treatment to Escitalopram in Patients with Major Depression and Obesity: A Randomized Clinical Trial. JAMA Psychiatry, 82, 759-767.
https://doi.org/10.1001/jamapsychiatry.2025.0801
[27] Phelps, N. H., Singleton, R. K., Zhou, B., Heap, R. A., Mishra, A., Bennett, J. E. et al. (2024). Worldwide Trends in Underweight and Obesity from 1990 to 2022: A Pooled Analysis of 3663 Population-Representative Studies with 222 Million Children, Adolescents, and Adults. The Lancet, 403, 1027-1050.
https://doi.org/10.1016/s0140-6736(23)02750-2
[28] Qin, H., Hu, G., Liang, Z., Jin, X., Chen, X., Su, B. et al. (2024). Association of Longitudinal Trajectories of General and Abdominal Adiposity during Middle Age with Mental Health and Well-Being in Late Life: A Prospective Analysis. Psychiatry Research, 335, Article 115863.
https://doi.org/10.1016/j.psychres.2024.115863
[29] Singh, A., Schurman, S. H., Bektas, A., Kaileh, M., Roy, R., Wilson, D. M. et al. (2024). Aging and Inflammation. Cold Spring Harbor Perspectives in Medicine, 14, a041197.
https://doi.org/10.1101/cshperspect.a041197
[30] Sopena-Rios, M., Ripoll-Cladellas, A., Omidi, F., Ballouz, S., Alquicira-Hernandez, J., Oelen, R. et al. (2026). Single-Cell Analysis of the Human Immune System Reveals Sex-Specific Dynamics of Immunosenescence. Nature Aging, 6, 932-949.
https://doi.org/10.1038/s43587-026-01099-x
[31] Tian, X., Xia, X., Zhang, Y., Xu, Q., & Wang, A. (2025). Prospective Associations of Dynapenic Abdominal Obesity Status with Distinct Trajectories of Depressive Symptoms: A National Cohort Study. Clinical Nutrition, 53, 270-277.
https://doi.org/10.1016/j.clnu.2025.05.007
[32] Wang, M., Yu, L., Tong, Z., Sun, G., Zhang, X., Zhang, Q. et al. (2026). Obesity, Metabolic Health, and Brain Health: Insights from a Prospective Cohort Study. Journal of Affective Disorders, 392, Article 120184.
https://doi.org/10.1016/j.jad.2025.120184
[33] Wang, R., Chen, Y., Teopiz, K. M. et al. (2025a). Additive Effects of Depression and Abdominal Obesity on Cognitive Function in Middle-Aged and Older Population: Evidence from Multinational Cohorts. BMC Medicine, 23, Article No. 555.
https://doi.org/10.1186/s12916-025-04298-2
[34] Wang, X., Liang, X., Jiang, M. et al. (2025b). Systemic Inflammation as a Mediator in the Link between Obesity and Depression: Evidence from a Nationwide Cohort Study. BMC Psychiatry, 25, Article No. 449.
https://doi.org/10.1186/s12888-025-06892-3
[35] World Health Organization (2012). Global Burden of Mental Disorders and the Need for a Comprehensive, Coordinated Response from Health and Social Sectors at the Country Level (EB130/9). In Executive Board, 130th Session. Provisional Agenda Item 6.2.
https://apps.who.int/gb/ebwha/pdf_files/EB130/b130_9-en.pdf
[36] Ye, Z., Yu, L., Li, Z., Huang, J., Lin, B., Xiang, B. et al. (2026). Immunosenescence, Inflammaging, and Metabolic Disease: A Geroscience Perspective on Mechanisms and Links. Experimental Gerontology, 224, Article 113320.
https://doi.org/10.1016/j.exger.2026.113320
[37] Zheng, Z. H., Tu, J. L., Li, X. H. et al. (2021). Neuroinflammation Induces Anxiety-and Depressive-Like Behavior by Modulating Neuronal Plasticity in the Basolateral Amygdala. Brain, Behavior, and Immunity, 91, 505-518.
https://doi.org/10.1016/j.bbi.2020.11.007